Related Experiment Video
Updated: Aug 11, 2026
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
Published on: February 16, 2015
The evolution of chemoradiation for glioblastoma: a modern success story
1Department of Radiation Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) Rue du Bugnon 46, CH-1011 LAUSANNE, Switzerland. rene-olivier.mirimanoff@chuv.ch
Abstract:
The dismal prognosis of glioblastoma had remained unchanged for the past 30 years until the association of temozolomide and radiotherapy in the breakthrough European Organization for Cancer/National Cancer Institute of Canada (EORTC/NCIC) trial brought new hope for patients. This trial will serve as a platform for new and exciting clinical and translational research areas. We review here the role of standard radiotherapy and chemotherapy in glioblastoma and the potential causes of their failure, and we focus on some of the aspects that led to the successful EORTC/NCIC trial and some of the related studies.
